サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1798373

クリニカルインテリジェンスの世界市場

Clinical Intelligence

出版日
ページ情報
英文 213 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.30円
クリニカルインテリジェンスの世界市場
出版日: 2025年08月26日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 213 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

クリニカルインテリジェンスの世界市場は2030年までに36億米ドルに達する

2024年に16億米ドルと推定されるクリニカルインテリジェンスの世界市場は、2024年から2030年にかけてCAGR 14.8%で成長し、2030年には36億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるソフトウェアコンポーネントは、CAGR 16.5%を記録し、分析期間終了時には24億米ドルに達すると予測されます。ハードウェアコンポーネント分野の成長率は、分析期間中CAGR 11.3％と推定されます。

米国市場は推定4億880万米ドル、中国はCAGR13.8％で成長予測

米国のクリニカルインテリジェンス市場は、2024年に4億880万米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年にかけてCAGR13.8%で推移し、2030年には5億4,800万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ13.8%と12.6%と予測されています。欧州では、ドイツがCAGR 10.6%で成長すると予測されています。

世界のクリニカルインテリジェンス市場- 主要動向と促進要因のまとめ

クリニカルインテリジェンスは世界のヘルスケアの意思決定をどのように変革しているか？

世界のクリニカルインテリジェンス市場は急激な変貌を遂げ、進化するヘルスケアの重要な柱となっています。世界中のヘルスケアシステムがデータ過多、患者数の増加、個別化医療への需要の高まりに取り組む中、クリニカルインテリジェンスは生データを実用的な洞察に変換する重要なツールとして台頭しています。このテクノロジーは、ビッグデータ分析、機械学習アルゴリズム、自然言語処理、リアルタイムの患者データ統合を活用し、臨床判断のサポート、患者の転帰の改善、業務の非効率性の低減を実現します。その応用範囲は、予測モデリングやリスク層別化から、集団健康管理や臨床ワークフローの最適化まで広がっています。北米、欧州、アジア太平洋などの地域の政府や保健機関は、価値ベースのケア提供を強化するため、クリニカルインテリジェンスを公衆衛生イニシアチブに統合する動きが加速しています。特筆すべきは、電子カルテ（EHR）や相互運用可能なシステムの普及によるヘルスケア記録の急速なデジタル化が、採用を大幅に加速していることです。さらに、患者中心のモデルを重視することで、診断と治療経路の間の情報ギャップを埋めることができる高度なツールが急務となっています。クリニカルインテリジェンスプラットフォームが膨大なデータセットを分析し、エビデンスに基づいた推奨をリアルタイムで提供する能力は、プレシジョン・メディシンを形成する上でその役割を推進し、急性期と慢性期の両方のケアマネジメントを変革しています。

なぜ病院やヘルスケアプロバイダーはクリニカルインテリジェンスソリューションを急速に導入しているのでしょうか？

病院やヘルスケアプロバイダーにおけるクリニカルインテリジェンスの需要は、主に臨床ワークフローの合理化、コスト削減、ケアの質向上の必要性によって高まっています。ヘルスケアがボリュームベースからバリューベースへとシフトする中、複雑な意思決定や予測分析をサポートできる、より高度で統合されたプラットフォームが求められています。クリニカルインテリジェンスシステムは現在、診断精度の向上、患者の転帰のモニタリング、高度な層別化モデルによる高リスク患者の特定による早期介入の促進のために導入されています。また、病院はこれらのシステムを活用して、人員配置から病床管理までリソースの利用を最適化し、業務効率を向上させています。さらに、ヘルスケアプロバイダーは規制の監視下に置かれることが増えているため、クリニカルインテリジェンスは文書化、コーディング、臨床ガイドラインの遵守を自動化することでコンプライアンスを支援しています。多くの大学医療センターや大規模な病院システムでは、EHRプラットフォームにインテリジェンスツールを組み込むことで、ポイントオブケアでの洞察を提供し、エラーを減らし、診断にかかる時間を短縮しています。さらに、測定可能なアウトカムを実証しなければならないというプレッシャーが、戦略的差別化要因としてクリニカルインテリジェンスを導入するよう医療機関を後押ししています。リアルタイムモニタリングツールとAI主導型アナリティクスの統合は、治療計画の適時性と正確性を高めると同時に、多職種チーム間のシームレスなコミュニケーションを促進します。これは、特に集中治療室（ICU）、救急部、腫瘍科など、一刻を争う意思決定が重要な場面で極めて重要です。この市場では、ヘルスケアITベンダーと病院が協力して、特定の医療機関のニーズに対応したクリニカルインテリジェンスシステムを共同開発する動きが加速しています。

規制の枠組みやデータセキュリティへの懸念は、市場の成長を阻害するのか、それとも加速させるのか？

クリニカルインテリジェンスは革新的なメリットを提供するが、その成長軌道は規制の枠組み、データガバナンス、サイバーセキュリティの課題によって大きく左右されます。米国のFDAや欧州のEMAなどの規制機関は、臨床意思決定におけるAIとアナリティクスの展開に関する基準を定義するために積極的に取り組んでいます。こうした規制は必要ではあるが、ソフトウェア開発サイクルやコンプライアンス・プロトコルに複雑さをもたらします。一方では、厳しい規制は新しいソリューションの承認と統合を遅らせる可能性があり、他方では、スケーラブルで倫理的なイノベーションのための構造化された経路を提供します。特にHIPAA、GDPR、様々な国の医療情報法のような枠組みにおいて、患者データのプライバシーがますます重視されているため、クリニカルインテリジェンスプラットフォームは強固な暗号化、匿名化、監査可能な機能を組み込む必要があります。臨床データは機密性が高く、病院や医療システムを標的にしたサイバー攻撃が頻発しているため、ヘルスケア組織にとってセキュリティは依然として最大の関心事です。これに対応するため、多くのベンダーは、高度なセキュリティレイヤーとリアルタイム監視機能を備えたプラットフォームを強化し、規制への準拠とユーザーの信頼の確保に努めています。同時に、クラウドインフラへの依存の高まりは、チャンスとリスクの両方をもたらします。クラウドベースのプラットフォームは、拡張性、リアルタイムアクセス、コスト効率を向上させる一方で、厳格なセキュリティプロトコルを要求します。興味深いことに、政府や保健省はデジタルヘルスの取り組みに資金を提供し、クリニカルインテリジェンスをサポートする安全で準拠したインフラの開発に予算を割くようになってきています。このような投資は、長期的な市場拡大につながる、より標準化された安全なエコシステムに貢献しています。

業界や地域を超えたクリニカルインテリジェンス市場の台頭の原動力は？

クリニカルインテリジェンス市場の成長は、テクノロジーの進歩、ヘルスケア提供モデルの転換、消費者の期待の進化、セクターを超えた協力関係の強化に根ざしたいくつかの要因によって促進されています。ヘルスケアITにおける人工知能、ディープラーニング、ビッグデータ分析の急速な導入は、クリニカルインテリジェンスツールの繁栄のための強力な基盤を作り出しています。自然言語処理の進歩により、医師のメモ、放射線報告書、臨床記録などの非構造化データから、より優れた洞察を抽出できるようになっています。これと並行して、相互運用可能なプラットフォームや医療情報交換（HIE）の台頭により、部門や機関を超えたシームレスなデータ共有が可能になり、分析ツールの有用性が高まっています。エンドユーザー側では、外来医療センター、診断ラボ、専門クリニックの拡大が、特定の使用事例に合わせたスケーラブルなシステムに対する需要を押し上げています。さらに、先進国、発展途上国を問わず、慢性疾患の蔓延と人口の高齢化が進んでいるため、データ主導の積極的なケア提供が必要となっています。消費者の行動も変化しており、患者はよりパーソナライズされた、透明性の高い、タイムリーなケアを期待しています。製薬会社は、クリニカルインテリジェンスを実際のエビデンス生成、臨床試験の最適化、医薬品の安全性モニタリングにますます活用し、さらなる需要の流れを生み出しています。最後に、ベンチャーキャピタルや官民パートナーシップによる資金調達に加え、テック大手とヘルスケアプロバイダーとの戦略的コラボレーションが、イノベーションサイクルの迅速化と市場浸透を促進しています。これらの集約的な要因は、市場を前進させるだけでなく、ヘルスケアのパラダイムを、ますます予測、予防、精密志向のものへと再構築しています。

セグメント

コンポーネント（ソフトウェア、ハードウェア、サービス）;タイプ（集団健康管理、レトロスペクティブ・パフォーマンス管理＆予測分析、臨床ベンチマーク、臨床意思決定支援システム、その他）;用途（収益サイクル管理クレーム、サプライチェーン、不正、その他）;最終用途（病院、診療所、その他）

調査対象企業の例

  • Ada Health
  • Allscripts
  • Beamtree
  • Cerner Corporation
  • Cerner Enviza
  • Cognizant
  • Datavant
  • EClinicalWorks
  • Epic Systems Corporation
  • GE HealthCare
  • H1 Inc.
  • IBM
  • ICON plc
  • McKesson Corporation
  • Medidata Solutions
  • Philips（Clinical layer）
  • QSI Management LLC
  • Siemens Healthineers
  • TruBridge
  • UnitedHealth Group
  • Veradigm

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP38633

Global Clinical Intelligence Market to Reach US$3.6 Billion by 2030

The global market for Clinical Intelligence estimated at US$1.6 Billion in the year 2024, is expected to reach US$3.6 Billion by 2030, growing at a CAGR of 14.8% over the analysis period 2024-2030. Software Component, one of the segments analyzed in the report, is expected to record a 16.5% CAGR and reach US$2.4 Billion by the end of the analysis period. Growth in the Hardware Component segment is estimated at 11.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$408.8 Million While China is Forecast to Grow at 13.8% CAGR

The Clinical Intelligence market in the U.S. is estimated at US$408.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$548.0 Million by the year 2030 trailing a CAGR of 13.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.8% and 12.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.6% CAGR.

Global Clinical Intelligence Market - Key Trends & Drivers Summarized

How Is Clinical Intelligence Transforming Healthcare Decision-Making Worldwide?

The global clinical intelligence market is undergoing a radical transformation, becoming an integral pillar of the evolving healthcare landscape. As healthcare systems around the world grapple with data overload, rising patient volumes, and growing demand for personalized care, clinical intelligence is emerging as a vital tool to translate raw data into actionable insights. This technology harnesses big data analytics, machine learning algorithms, natural language processing, and real-time patient data integration to provide clinical decision support, improve patient outcomes, and reduce operational inefficiencies. Its applications extend from predictive modeling and risk stratification to population health management and clinical workflow optimization. Governments and health agencies in regions such as North America, Europe, and Asia-Pacific are increasingly integrating clinical intelligence into public health initiatives to enhance value-based care delivery. Notably, the rapid digitization of healthcare records, with electronic health records (EHR) and interoperable systems gaining traction, is significantly accelerating adoption. Moreover, the focus on patient-centric models has created a pressing need for advanced tools that can bridge the information gap between diagnosis and treatment pathways. The ability of clinical intelligence platforms to analyze vast datasets and deliver real-time, evidence-based recommendations is propelling their role in shaping precision medicine, thus transforming both acute and chronic care management.

Why Are Hospitals and Healthcare Providers Rapidly Adopting Clinical Intelligence Solutions?

The demand for clinical intelligence among hospitals and healthcare providers is escalating, primarily driven by the need to streamline clinical workflows, reduce costs, and enhance care quality. As healthcare institutions shift from volume-based to value-based care, they require more advanced, integrated platforms capable of supporting complex decision-making and predictive analytics. Clinical intelligence systems are now being deployed to improve diagnostic accuracy, monitor patient outcomes, and facilitate early intervention by identifying high-risk patients through advanced stratification models. Hospitals are also utilizing these systems to optimize resource utilization, from staffing to bed management, thereby improving operational efficiency. Furthermore, with healthcare providers under increasing regulatory scrutiny, clinical intelligence aids in compliance by automating documentation, coding, and adherence to clinical guidelines. Many academic medical centers and large hospital systems are embedding intelligence tools into EHR platforms to deliver point-of-care insights, reduce errors, and shorten the diagnostic journey. Additionally, the pressure to demonstrate measurable outcomes is pushing institutions to adopt clinical intelligence as a strategic differentiator. The integration of real-time monitoring tools with AI-driven analytics is enhancing the timeliness and accuracy of treatment plans, while facilitating seamless communication across multidisciplinary teams. This is particularly crucial in intensive care units (ICUs), emergency departments, and oncology settings where time-sensitive decisions are critical. The market is witnessing a surge in collaborations between healthcare IT vendors and hospitals to co-develop tailored clinical intelligence systems that can cater to specific institutional needs.

Could Regulatory Frameworks and Data Security Concerns Hinder or Accelerate Market Growth?

While clinical intelligence offers transformative benefits, its growth trajectory is shaped significantly by regulatory frameworks, data governance, and cybersecurity challenges. Regulatory bodies such as the FDA in the United States and the EMA in Europe are actively working to define standards for the deployment of AI and analytics in clinical decision-making. These regulations, although necessary, introduce complexities in software development cycles and compliance protocols. On the one hand, stringent regulations may delay the approval and integration of new solutions; on the other hand, they offer a structured pathway for scalable and ethical innovation. The increasing emphasis on patient data privacy, especially under frameworks like HIPAA, GDPR, and various national health information acts, requires that clinical intelligence platforms incorporate robust encryption, anonymization, and auditability features. Security remains a top concern for healthcare organizations due to the sensitive nature of clinical data and the growing frequency of cyberattacks targeting hospitals and health systems. In response, many vendors are enhancing their platforms with advanced security layers and real-time monitoring to ensure regulatory compliance and instill user trust. At the same time, the growing reliance on cloud infrastructure introduces both opportunities and risks. While cloud-based platforms improve scalability, real-time access, and cost-effectiveness, they also demand rigorous security protocols. Interestingly, governments and health ministries are increasingly funding digital health initiatives and allocating budgets toward the development of secure, compliant infrastructure that supports clinical intelligence. These investments are contributing to a more standardized and secure ecosystem that is conducive to long-term market expansion.

What Is Fueling the Rise of the Clinical Intelligence Market Across Industries and Geographies?

The growth in the clinical intelligence market is driven by several factors rooted in technological advancements, shifting healthcare delivery models, evolving consumer expectations, and increased cross-sector collaboration. The rapid adoption of artificial intelligence, deep learning, and big data analytics in healthcare IT is creating a strong foundation for clinical intelligence tools to flourish. Advances in natural language processing are enabling better extraction of insights from unstructured data such as physician notes, radiology reports, and clinical transcripts. In parallel, the rise of interoperable platforms and Health Information Exchanges (HIEs) is allowing seamless data sharing across departments and institutions, thereby enhancing the utility of analytics tools. On the end-user front, the expanding footprint of ambulatory care centers, diagnostic labs, and specialized clinics is boosting demand for scalable clinical intelligence systems tailored for specific use cases. Furthermore, the increasing prevalence of chronic diseases, coupled with aging populations in developed and developing nations alike, is necessitating proactive, data-driven approaches to care delivery. Consumer behavior is also shifting, with patients expecting more personalized, transparent, and timely care - expectations that clinical intelligence is uniquely positioned to meet. Pharmaceutical companies are increasingly leveraging clinical intelligence for real-world evidence generation, clinical trial optimization, and drug safety monitoring, creating additional demand streams. Finally, strategic collaborations between tech giants and healthcare providers, alongside funding from venture capital and public-private partnerships, are facilitating faster innovation cycles and wider market penetration. These converging factors are not only propelling the market forward but also reshaping the healthcare paradigm toward one that is increasingly predictive, preventive, and precision-oriented.

SCOPE OF STUDY:

The report analyzes the Clinical Intelligence market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Software Component, Hardware Component, Services Component); Type (Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System, Other Types); Application (Revenue Cycle Management Claims Application, Supply Chain Application, Fraud Application, Other Applications); End-Use (Hospitals End-Use, Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 43 Featured) -

  • Ada Health
  • Allscripts
  • Beamtree
  • Cerner Corporation
  • Cerner Enviza
  • Cognizant
  • Datavant
  • EClinicalWorks
  • Epic Systems Corporation
  • GE HealthCare
  • H1 Inc.
  • IBM
  • ICON plc
  • McKesson Corporation
  • Medidata Solutions
  • Philips (Clinical layer)
  • QSI Management LLC
  • Siemens Healthineers
  • TruBridge
  • UnitedHealth Group
  • Veradigm

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Clinical Intelligence - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • AI-Powered Diagnostics Propel Growth in Real-Time Clinical Intelligence Platforms
    • Shift Toward Value-Based Care Expands Addressable Market for Predictive Health Analytics
    • Here's How Population Health Management Is Driving Demand for Longitudinal Patient Data Insights
    • Rising Chronic Disease Burden Strengthens the Business Case for Integrated Clinical Decision Support Systems
    • Surge in Virtual Care Models Accelerates Demand for Remote Patient Monitoring and Risk Stratification Tools
    • Clinical Workflow Optimization Needs Drive Adoption of Intelligent Automation in EHR Ecosystems
    • Here's the Story: How Clinician Burnout Is Fueling Growth in AI-Supported Decision Workflows
    • Precision Medicine Initiatives Generate Demand for Genomic and Biomarker-Driven Intelligence Layers
    • Digital Therapeutics Integration Expands the Role of Clinical Intelligence in Personalized Care Pathways
    • Advanced Imaging and Diagnostic Modalities Strengthen Demand for Multimodal Data Aggregation Tools
    • Cybersecurity Concerns and Data Governance Requirements Spur Development of Secure Clinical Intelligence Systems
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Clinical Intelligence Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Clinical Intelligence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Clinical Intelligence by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Software Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Software Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Hardware Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Hardware Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Services Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Services Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Supply Chain Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Supply Chain Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Fraud Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Fraud Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Revenue Cycle Management Claims Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Revenue Cycle Management Claims Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Population Health Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Population Health Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Retrospective Performance Management & Predictive Analytics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Retrospective Performance Management & Predictive Analytics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Clinical Benchmarking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Clinical Benchmarking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Clinical Decision Support System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Clinical Decision Support System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World 6-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Clinical Intelligence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 34: USA Recent Past, Current & Future Analysis for Clinical Intelligence by Component - Software Component, Hardware Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Clinical Intelligence by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services Component for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Clinical Intelligence by Application - Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Clinical Intelligence by Application - Percentage Breakdown of Value Sales for Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application for the Years 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Clinical Intelligence by End-Use - Hospitals End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Clinical Intelligence by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for Clinical Intelligence by Type - Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: USA 6-Year Perspective for Clinical Intelligence by Type - Percentage Breakdown of Value Sales for Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types for the Years 2025 & 2030
  • CANADA
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Clinical Intelligence by Component - Software Component, Hardware Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for Clinical Intelligence by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services Component for the Years 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Clinical Intelligence by Application - Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Clinical Intelligence by Application - Percentage Breakdown of Value Sales for Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application for the Years 2025 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Clinical Intelligence by End-Use - Hospitals End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Clinical Intelligence by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Clinical Intelligence by Type - Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Canada 6-Year Perspective for Clinical Intelligence by Type - Percentage Breakdown of Value Sales for Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types for the Years 2025 & 2030
  • JAPAN
    • Clinical Intelligence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Clinical Intelligence by Component - Software Component, Hardware Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan 6-Year Perspective for Clinical Intelligence by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services Component for the Years 2025 & 2030
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Clinical Intelligence by Application - Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Japan 6-Year Perspective for Clinical Intelligence by Application - Percentage Breakdown of Value Sales for Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application for the Years 2025 & 2030
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Clinical Intelligence by End-Use - Hospitals End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Clinical Intelligence by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Clinical Intelligence by Type - Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for Clinical Intelligence by Type - Percentage Breakdown of Value Sales for Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types for the Years 2025 & 2030
  • CHINA
    • Clinical Intelligence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 58: China Recent Past, Current & Future Analysis for Clinical Intelligence by Component - Software Component, Hardware Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: China 6-Year Perspective for Clinical Intelligence by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services Component for the Years 2025 & 2030
    • TABLE 60: China Recent Past, Current & Future Analysis for Clinical Intelligence by Application - Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: China 6-Year Perspective for Clinical Intelligence by Application - Percentage Breakdown of Value Sales for Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application for the Years 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Clinical Intelligence by End-Use - Hospitals End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for Clinical Intelligence by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for Clinical Intelligence by Type - Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for Clinical Intelligence by Type - Percentage Breakdown of Value Sales for Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types for the Years 2025 & 2030
  • EUROPE
    • Clinical Intelligence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Clinical Intelligence by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 67: Europe 6-Year Perspective for Clinical Intelligence by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Clinical Intelligence by Component - Software Component, Hardware Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Clinical Intelligence by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services Component for the Years 2025 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Clinical Intelligence by Application - Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Clinical Intelligence by Application - Percentage Breakdown of Value Sales for Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application for the Years 2025 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Clinical Intelligence by End-Use - Hospitals End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for Clinical Intelligence by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Clinical Intelligence by Type - Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for Clinical Intelligence by Type - Percentage Breakdown of Value Sales for Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types for the Years 2025 & 2030
  • FRANCE
    • Clinical Intelligence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 76: France Recent Past, Current & Future Analysis for Clinical Intelligence by Component - Software Component, Hardware Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: France 6-Year Perspective for Clinical Intelligence by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services Component for the Years 2025 & 2030
    • TABLE 78: France Recent Past, Current & Future Analysis for Clinical Intelligence by Application - Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: France 6-Year Perspective for Clinical Intelligence by Application - Percentage Breakdown of Value Sales for Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application for the Years 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Clinical Intelligence by End-Use - Hospitals End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France 6-Year Perspective for Clinical Intelligence by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 82: France Recent Past, Current & Future Analysis for Clinical Intelligence by Type - Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: France 6-Year Perspective for Clinical Intelligence by Type - Percentage Breakdown of Value Sales for Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types for the Years 2025 & 2030
  • GERMANY
    • Clinical Intelligence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Clinical Intelligence by Component - Software Component, Hardware Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Germany 6-Year Perspective for Clinical Intelligence by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services Component for the Years 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Clinical Intelligence by Application - Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany 6-Year Perspective for Clinical Intelligence by Application - Percentage Breakdown of Value Sales for Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application for the Years 2025 & 2030
    • TABLE 88: Germany Recent Past, Current & Future Analysis for Clinical Intelligence by End-Use - Hospitals End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Germany 6-Year Perspective for Clinical Intelligence by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 90: Germany Recent Past, Current & Future Analysis for Clinical Intelligence by Type - Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Germany 6-Year Perspective for Clinical Intelligence by Type - Percentage Breakdown of Value Sales for Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types for the Years 2025 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Clinical Intelligence by Component - Software Component, Hardware Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy 6-Year Perspective for Clinical Intelligence by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services Component for the Years 2025 & 2030
    • TABLE 94: Italy Recent Past, Current & Future Analysis for Clinical Intelligence by Application - Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Italy 6-Year Perspective for Clinical Intelligence by Application - Percentage Breakdown of Value Sales for Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application for the Years 2025 & 2030
    • TABLE 96: Italy Recent Past, Current & Future Analysis for Clinical Intelligence by End-Use - Hospitals End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Italy 6-Year Perspective for Clinical Intelligence by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Clinical Intelligence by Type - Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy 6-Year Perspective for Clinical Intelligence by Type - Percentage Breakdown of Value Sales for Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types for the Years 2025 & 2030
  • UNITED KINGDOM
    • Clinical Intelligence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 100: UK Recent Past, Current & Future Analysis for Clinical Intelligence by Component - Software Component, Hardware Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: UK 6-Year Perspective for Clinical Intelligence by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services Component for the Years 2025 & 2030
    • TABLE 102: UK Recent Past, Current & Future Analysis for Clinical Intelligence by Application - Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: UK 6-Year Perspective for Clinical Intelligence by Application - Percentage Breakdown of Value Sales for Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application for the Years 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Clinical Intelligence by End-Use - Hospitals End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK 6-Year Perspective for Clinical Intelligence by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 106: UK Recent Past, Current & Future Analysis for Clinical Intelligence by Type - Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: UK 6-Year Perspective for Clinical Intelligence by Type - Percentage Breakdown of Value Sales for Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Clinical Intelligence by Component - Software Component, Hardware Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 6-Year Perspective for Clinical Intelligence by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services Component for the Years 2025 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Clinical Intelligence by Application - Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe 6-Year Perspective for Clinical Intelligence by Application - Percentage Breakdown of Value Sales for Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application for the Years 2025 & 2030
    • TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for Clinical Intelligence by End-Use - Hospitals End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Rest of Europe 6-Year Perspective for Clinical Intelligence by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 114: Rest of Europe Recent Past, Current & Future Analysis for Clinical Intelligence by Type - Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Rest of Europe 6-Year Perspective for Clinical Intelligence by Type - Percentage Breakdown of Value Sales for Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Clinical Intelligence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Intelligence by Component - Software Component, Hardware Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 6-Year Perspective for Clinical Intelligence by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services Component for the Years 2025 & 2030
    • TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Intelligence by Application - Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Asia-Pacific 6-Year Perspective for Clinical Intelligence by Application - Percentage Breakdown of Value Sales for Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application for the Years 2025 & 2030
    • TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Intelligence by End-Use - Hospitals End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Asia-Pacific 6-Year Perspective for Clinical Intelligence by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Intelligence by Type - Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific 6-Year Perspective for Clinical Intelligence by Type - Percentage Breakdown of Value Sales for Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Clinical Intelligence by Component - Software Component, Hardware Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of World 6-Year Perspective for Clinical Intelligence by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services Component for the Years 2025 & 2030
    • TABLE 126: Rest of World Recent Past, Current & Future Analysis for Clinical Intelligence by Application - Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of World 6-Year Perspective for Clinical Intelligence by Application - Percentage Breakdown of Value Sales for Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application for the Years 2025 & 2030
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Clinical Intelligence by End-Use - Hospitals End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of World 6-Year Perspective for Clinical Intelligence by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 130: Rest of World Recent Past, Current & Future Analysis for Clinical Intelligence by Type - Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Rest of World 6-Year Perspective for Clinical Intelligence by Type - Percentage Breakdown of Value Sales for Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types for the Years 2025 & 2030

IV. COMPETITION